New vaccine combo could simplify infant shots
NCT ID NCT06824181
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This Phase 3 study tests whether mixing a new 21-valent pneumococcal vaccine with a licensed 20-valent version is safe and helps build immunity in healthy infants. About 580 babies will receive different combinations of the vaccines at routine checkups. The goal is to see if flexible schedules work as well as the standard series.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- 21-valent pneumococcal conjugate vaccine (PCV21) and 20-valent pneumococcal conjugate vaccine (Prevnar 20)
- What this could lead to
- If successful, this could show that mixing different pneumococcal vaccines is safe and effective, potentially offering more flexible vaccination schedules for infants.
- What could go wrong
- This is a Phase 3 trial, but results may not apply to all populations. The study is still ongoing, and the final outcomes on safety and immune response are not yet known.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PNEUMOCOCCAL IMMUNIZATION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Atlantis Clinical Research- Site Number : 8400009
Miami, Florida, 33173, United States
-
Carolina Family Care - Charleston- Site Number : 8400014
Charleston, South Carolina, 29414, United States
-
Clinsearch Inc at Dr. Gala, LLC- Site Number : 8400027
Miami, Florida, 33135, United States
-
Clinsearch Inc at VAST Clinical Research- Site Number : 8400028
Euless, Texas, 76040, United States
-
DM Clinical Research - Houston - Jones Road- Site Number : 8400012
Houston, Texas, 77065, United States
-
Finger Lakes Medical Research - Cortland- Site Number : 8400022
Cortland, New York, 13045, United States
-
Helios Clinical Research - BUR PEDI- Site Number : 8400016
Burleson, Texas, 76028, United States
-
Investigational Site Number : 1520001
Santiago, Reg Metropolitana de Santiago, 8880465, Chile
-
Investigational Site Number : 1520002
Santiago, Reg Metropolitana de Santiago, 8380418, Chile
-
Investigational Site Number : 1520003
Santiago, Reg Metropolitana de Santiago, 8330034, Chile
-
Investigational Site Number : 4840001
Mexico City, Mexico City, 04530, Mexico
-
Investigational Site Number : 4840002
Temixco, Morelos, 62587, Mexico
-
Investigational Site Number : 4840003
León, Guanajuato, 37320, Mexico
-
Investigational Site Number : 4840004
Tlaltizapán, Morelos, 62770, Mexico
-
Investigational Site Number : 6080001
Cebu City, 6000, Philippines
-
Investigational Site Number : 6080002
Quezon City, 1100, Philippines
-
Investigational Site Number : 6080003
Quezon City, 1121, Philippines
-
Javara - Privia Medical Group North Texas - Stephenville- Site Number : 8400024
Stephenville, Texas, 76401, United States
-
Kaiser Permanente - Los Angeles Medical Center- Site Number : 8400025
Los Angeles, California, 90027, United States
-
Kid's Way Pediatrics- Site Number : 8400013
Hermitage, Pennsylvania, 16148, United States
-
Private Practice - Dr. Michael W. Simon- Site Number : 8400001
Lexington, Kentucky, 40517, United States
-
SUNY Upstate Medical University - Syracuse- Site Number : 8400015
Syracuse, New York, 13210, United States
-
The Medici Medical Research- Site Number : 8400008
Hollywood, Florida, 33021, United States
-
University of Rochester Medical Center- Site Number : 8400019
Rochester, New York, 14642, United States
-
University of Texas Medical Branch at Galveston- Site Number : 8400005
League City, Texas, 77555, United States
-
Velocity Clinical Research - New Orleans- Site Number : 8400006
New Orleans, Louisiana, 70119, United States
-
Velocity Clinical Research - Sioux City- Site Number : 8400007
Sioux City, Iowa, 51106, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- New vaccine aims to shield infants from pneumonia
- New 21-Strain pneumonia vaccine shows promise in infant trial
- Korean study monitors prevenar 20 vaccine safety
- New 21-Valent vaccine aims to shield babies from pneumonia and meningitis
- New vaccine targets 21 pneumonia strains in infant trial
- New pneumonia vaccine shows promise in older adults